Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher E Brightling

Showing results (191-200 of 254) with videos related to

Pageof 26
Sort By:
Cell Reports|November 21, 2025
Environmental exposure augments the abundance and transferability of antibiotic resistance genes in the respiratory tractXinzhu Yi, Hanqin Cai, Haiyue Liu, et al.
Nature Cardiovascular Research|December 16, 2025
Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestryArt Schuermans, Andreas Verstraete, Vilma Lammi, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2011
Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkersMona Bafadhel, Susan McKenna, Sarah Terry, et al.
The Lancet. Respiratory Medicine|October 2, 2025
Assessment of the role of small airway dysfunction in relation to exacerbation risk in patients with well controlled asthma (ATLANTIS): an observational studyStanley P Galant, Pauline J M Kuks, Tessa M Kole, et al.
Allergy|November 10, 2025
Cluster Analysis to Identify Distinct Asthma Phenotypes in the ATLANTIS CohortPauline J M Kuks, Tatiana Karp, Jorine E Hartman, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestryArt Schuermans, Andreas Verstraete, Vilma Lammi, et al.
Thorax|December 23, 2017
Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP studyZhang Wang, Richa Singh, Bruce E Miller, et al.
The New England Journal of Medicine|May 22, 2019
Benralizumab for the Prevention of COPD ExacerbationsGerard J Criner, Bartolome R Celli, Christopher E Brightling, et al.
The Lancet. Respiratory Medicine|March 27, 2022
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trialAhmed J Yousuf, Seid Mohammed, Liesl Carr, et al.
BMJ Open|March 6, 2025
Assessing the impact of COmorbidities and Sociodemographic factors on Multiorgan Injury following COVID-19: rationale and protocol design of COSMIC, a UK multicentre observational study of COVID-negative controlsSimran Shergill, Mohamed Elshibly, Sandeep S Hothi, et al.
Pageof 26

Showing results (191-200 of 254) with videos related to

Sort By:
Pageof 26
Cell Reports|November 21, 2025
Environmental exposure augments the abundance and transferability of antibiotic resistance genes in the respiratory tractXinzhu Yi, Hanqin Cai, Haiyue Liu, et al.
Nature Cardiovascular Research|December 16, 2025
Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestryArt Schuermans, Andreas Verstraete, Vilma Lammi, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2011
Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkersMona Bafadhel, Susan McKenna, Sarah Terry, et al.
The Lancet. Respiratory Medicine|October 2, 2025
Assessment of the role of small airway dysfunction in relation to exacerbation risk in patients with well controlled asthma (ATLANTIS): an observational studyStanley P Galant, Pauline J M Kuks, Tessa M Kole, et al.
Allergy|November 10, 2025
Cluster Analysis to Identify Distinct Asthma Phenotypes in the ATLANTIS CohortPauline J M Kuks, Tatiana Karp, Jorine E Hartman, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
Human genetics implicate thromboembolism in the pathogenesis of long COVID in individuals of European ancestryArt Schuermans, Andreas Verstraete, Vilma Lammi, et al.
Thorax|December 23, 2017
Sputum microbiome temporal variability and dysbiosis in chronic obstructive pulmonary disease exacerbations: an analysis of the COPDMAP studyZhang Wang, Richa Singh, Bruce E Miller, et al.
The New England Journal of Medicine|May 22, 2019
Benralizumab for the Prevention of COPD ExacerbationsGerard J Criner, Bartolome R Celli, Christopher E Brightling, et al.
The Lancet. Respiratory Medicine|March 27, 2022
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trialAhmed J Yousuf, Seid Mohammed, Liesl Carr, et al.
BMJ Open|March 6, 2025
Assessing the impact of COmorbidities and Sociodemographic factors on Multiorgan Injury following COVID-19: rationale and protocol design of COSMIC, a UK multicentre observational study of COVID-negative controlsSimran Shergill, Mohamed Elshibly, Sandeep S Hothi, et al.
Pageof 26